Skip to content
Science

Novotech Releases Report on Global Bladder Cancer Clinical Trials, Offering Insights for Oncology Advancement

Novotech 2 mins read
SYDNEY--BUSINESS WIRE--

Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released an in-depth report, Bladder Cancer – Global Clinical Trial Landscape 2024, offering key insights for stakeholders across the oncology and clinical research sectors.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241120379204/en/

Bladder cancer remains a significant health challenge worldwide, with over 614,000 new cases and 220,600 deaths recorded in 2022. Novotech’s latest report provides a detailed examination of the evolving landscape in bladder cancer research, with a focus on clinical trial trends, emerging therapeutic strategies, and regional variations in patient outcomes.

Key Highlights from the Report:

  • Bladder Cancer Statistics: A thorough analysis of incidence and survival data, highlighting that Europe and Asia account for the majority of global cases.
  • Clinical Trial Landscape: An overview of over 1,500 bladder cancer clinical trials initiated since 2019, with North America, Asia-Pacific, and Europe leading in trial volume.
  • Advancements in Treatment: Exploration of innovative therapies, including immunotherapy, targeted treatments, and combination therapies, which are opening new avenues in bladder cancer care.
  • Future Projections: Bladder cancer cases are projected to exceed 1.2 million annually by 2050, underscoring the urgent need for advanced treatment options and accessible healthcare solutions.

This report explores valuable information for biotech professionals, oncologists, researchers and scientists. By examining trial density, recruitment efficiencies, and regional disparities in treatment outcomes, the report provides actionable insights for those aiming to enhance the efficiency and effectiveness of bladder cancer trials.

Download the Full Report

To access the full report and gain a deeper understanding of the trends shaping bladder cancer research, download the report here.

About NovotechNovotech-CRO.com

Founded in 1997, Novotech is a global full-service clinical Contract Research Organization (CRO) focused on partnering with biotech companies to accelerate the development of advanced and novel therapeutics at every phase.

Recognized for its industry-leading contributions, Novotech has received numerous prestigious awards, including the Frost & Sullivan 2024 Global Biotech CRO of the year award, Clinical Trials Arena Excellence Awards 2024, 2024 Employer of Choice, 2024 Great Place to Work in the US, 2024 Brandon Hall Gold Award, CRO Leadership Award 2023, the Asia Pacific Cell & Gene Therapy Clinical Trials Excellence 2023, the Asia-Pacific Contract Research Organization Company of the Year Award since 2006.

The Company offers a comprehensive suite of services including laboratories, Phase I facilities, drug development consulting, regulatory expertise, and has experience with over 5,000 clinical projects, including Phase I to Phase IV clinical trials and bioequivalence studies. With a presence in 34 office locations and a dedicated team of 3,000+ professionals worldwide, Novotech is a trusted end-to-end strategic partner of choice.

For more information or to speak to an expert team member visit www.Novotech-CRO.com


Contact details:

Media
Toyna Chin
mediacontact@novotech-cro.com
USA: +1 415 364 8135

Media

More from this category

  • Engineering, Science
  • 05/12/2024
  • 09:45
UNSW Sydney

‘A million times better’: how frequency combs could provide a quantum leap for Satellite Network Synchronisation

Engineers at UNSW say exciting new developments in the way optical clocks can be synchronised has the potential to radically change global positioning systems – as well as fundamental cosmological theories. Satellites in space need to synchronise very precisely in order for communications to proceed efficiently. Synchronisation also allows the time taken for signals to be sent across a network to be calculated, which then allows positioning to be determined. Currently global positioning is accurate in most circumstances to within about 1 metre, but if the timing of signals is miscalculated by just 1 nanosecond the error would be a…

  • Energy, Science
  • 04/12/2024
  • 11:46
Charles Darwin University

CDU EXPERT: Ouch! Why do everyday objects keep zapping me?

4 DECEMBER, 2024 Who: AI expert and adjunct Associate Professor at Charles Darwin University in the Faculty of Science and Technology, and Associate Professor at Australian Catholic University Associate Professor Niusha Shafiabady. Associate Professor Shafiabady is an internationally recognised expert and developer of AI data analysis platform Ai-Labz. Topics: The discovery of static electricity, and how it works. How to avoid being zapped by static electricity. Contact details: Call +61 8 8946 6721 or email media@cdu.edu.au to arrange an interview. Quotes attributable to Associate Professor Shafiabady: “Static charge is inconvenient, but it is not dangerous except in places where we…

  • Energy, Science
  • 04/12/2024
  • 07:33
UNSW Sydney

Proton batteries: an innovative option for the future of energy storage

An eco-friendly, high-performance organic battery is being developed by scientists at UNSW Sydney. A team of scientists atUNSW Chemistryhave successfully developed an organic material that is able to store protons –and they have used it to create a rechargeable proton battery in the lab. By leveraging hydrogen ions – protons – instead of traditional lithium, these batteries hold promise for addressing some of the critical challenges in modern energy storage, including resource scarcity, environmental impact, safety and cost. The latest findings, recently published in the journalAngewandte Chemie, highlight the battery’s ability to store energy quickly, last longer, and perform well…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.